Literature DB >> 10317694

The defined daily dose system (DDD) for drug utilization review.

A I Wertheimer.   

Abstract

The defined daily dose (DDD) system for use in utilization studies is presented for consideration by pharmacy and therapeutics committee members as an additional tool for drug utilization review and drug regimen review activities. The article describes the development and nature of the DDD system and provides examples of its format, benefits, and limitations. Essentially, the DDD system was devised by the Nordic Council on Medicines, and the early work was done in Norway with the Anatomical Therapeutic Chemical (ATC) diagnostic code system. Whereas consumption andutilization studies in North America have focused on the prescribing by an individual physician and drug utilization for an individual patient, the Scandinavians have attempted a macroscopic focus on the total consumption of drugs for a county or country or other definable political or geographic region. The sale of the drugs is divided by what is agreed on as an average daily dose to yield a unit of measure called the DDD, which is valuable for comparative studies. The DDD system and its component aspects are presented so that hospital pharmacists may evaluate its benefits for potential use in North America.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 10317694

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  23 in total

Review 1.  Prescription data as a tool in pharmacotherapy audit (I). General considerations.

Authors:  C S de Vries; T F Tromp; W Blijleven; L T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  1999-04

2.  Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).

Authors:  Frantz Thiessard; Emmanuel Roux; Ghada Miremont-Salamé; Annie Fourrier-Réglat; Françoise Haramburu; Pascale Tubert-Bitter; Bernard Bégaud
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample.

Authors:  Mai Duong; Abdelilah Abouelfath; Regis Lassalle; Cécile Droz; Patrick Blin; Nicholas Moore
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

4.  Use of antimicrobials in Swiss hospitals. Swiss Committee of Anti-Infective Agents.

Authors:  D P Lew; J Garbino; A U Gerber; P Sudre
Journal:  Drugs       Date:  1996       Impact factor: 9.546

5.  Evaluating ethnic differences in the prescription of NSAIDs for chronic kidney disease: a cross-sectional survey of patients in general practice.

Authors:  Sally Hull; Rohini Mathur; Gavin Dreyer; Muhammad Magdi Yaqoob
Journal:  Br J Gen Pract       Date:  2014-07       Impact factor: 5.386

6.  Cost effectiveness of three drugs for the treatment of S. aureus infections in Nigeria.

Authors:  Ismail Ayinla Suleiman; Babajide Solomon Bamiro; Fola Tayo
Journal:  Int J Clin Pharm       Date:  2012-07-22

7.  Metabolic and inflammatory genes in schizophrenia.

Authors:  Kayla A Chase; Cherise Rosen; Hannah Gin; Olivia Bjorkquist; Benjamin Feiner; Robert Marvin; Sean Conrin; Rajiv P Sharma
Journal:  Psychiatry Res       Date:  2014-11-13       Impact factor: 3.222

8.  Application of the ATC/DDD methodology to monitor antibiotic drug use.

Authors:  S Natsch; Y A Hekster; R de Jong; E R Heerdink; R M Herings; J W van der Meer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

9.  Dispensing of psychotropic drugs to adults in community pharmacies in Latvia.

Authors:  Kristine Vrublevska; Jurita Rukmane; Rihards Burmistrs; Janis Sipols; Ruta Muceniece
Journal:  Pharm World Sci       Date:  2008-10-07

10.  A possible effect of montelukast on neurological aging examined by the use of register data.

Authors:  Bjørn Grinde; Henrik Schirmer; Anne Elise Eggen; Ludwig Aigner; Bo Engdahl
Journal:  Int J Clin Pharm       Date:  2020-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.